JB Chemicals moves up on getting USFDA's nod for Carbamazepine Extended Release Tablets

27 Apr 2020 Evaluate
JB Chemicals & Pharmaceuticals is currently trading at Rs. 563.70, up by 11.05 points or 2.00% from its previous closing of Rs. 552.65 on the BSE.

The scrip opened at Rs. 559.95 and has touched a high and low of Rs. 567.70 and Rs. 557.45 respectively. So far 8035 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 599.00 on 14-Feb-2020 and a 52 week low of Rs. 307.00 on 10-May-2019.

Last one week high and low of the scrip stood at Rs. 588.05 and Rs. 544.00 respectively. The current market cap of the company is Rs. 4351.37 crore.

The promoters holding in the company stood at 55.68%, while Institutions and Non-Institutions held 21.19% and 23.13% respectively.

JB Chemicals & Pharmaceuticals has received approval for its Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (US FDA) for Carbamazepine Extended Release Tablets USP 100 mg, 200 mg and 400 mg. (for treatment of Epilepsy and Trigeminal Neuralgia). The product is a generic version of Tegretol XR tablet in the same strength of Novartis Pharmaceuticals Corp. According to IQVIA, US sales were approximately USD 128 million.

The company plans to commercialize this product in Q3 of this financial year and is expected to boost the company's US sales.

JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).

JB Chem & Pharma Share Price

1823.95 0.85 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×